Results 81 to 90 of about 4,868 (220)

Deceleration Capacity as a Marker of Autonomic Cardiac Modulation in Prodromal and Manifest Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy

open access: yesEuropean Journal of Neurology, Volume 32, Issue 11, November 2025.
Objective: Heart rate variability (HRV) is a promising tool for autonomic dysfunction assessment, especially Deceleration capacity (DC), a sensitive parasympathetic marker. M&M: Study in patients with isolated REM sleep behavior disorder, Parkinson's disease, multiple system atrophy, and supranuclear palsy as compared to healthy control subjects ...
Elisabeth Ruppert   +9 more
wiley   +1 more source

Natural history of falls in an incident cohort of Parkinson’s disease: early evolution, risk and protective features [PDF]

open access: yes, 2017
The natural history of falls in early Parkinson’s disease (PD) is poorly understood despite the profound effect of falls on outcome. The primary aim of this study was to describe the natural history of falls, and characterise fallers over 54 months in 99
Burn, David   +6 more
core   +3 more sources

2198 Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension

open access: yesJournal of Clinical and Translational Science, 2018
OBJECTIVES/SPECIFIC AIMS: To describe adverse behavioral symptoms attributed to droxidopa therapy for neurogenic orthostatic hypotension (nOH). METHODS/STUDY POPULATION: BACKGROUND: Droxidopa, a norepinephrine (NE) precursor, improves symptoms of nOH by ...
Katherine McDonell   +4 more
doaj   +1 more source

Orthostatic hypotension in a cohort of hypertensive patients referring to a hypertension clinic [PDF]

open access: yes, 2015
n/
Di Stefano, C   +7 more
core   +1 more source

Central Nervous System Involvement as the Initial Manifestation of Transthyretin Amyloidosis: A Case Report and Literature Review

open access: yesiRADIOLOGY, Volume 3, Issue 5, Page 388-396, October 2025.
We reported a patient who presented with transient focal neurological symptoms. The contrast‐enhanced brain magnetic resonance imaging (MRI) of this patient demonstrated significant enhancement of the dura mater, pia mater, and spinal meninges. Based on the positive result of single photon emission computed tomography (SPECT), we promptly determined ...
Fen Li   +6 more
wiley   +1 more source

Longitudinal Trajectory of Multimodal Markers in a Patient with Isolated REM Sleep Behavior Disorder

open access: yes
Movement Disorders, EarlyView.
Seohee Choi   +7 more
wiley   +1 more source

Investigating Dopamine Replacement–Associated Fluctuations in Cognition and Mood in Cognitively Unimpaired Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, Volume 12, Issue 10, Page 1609-1614, October 2025.
Abstract Background Non‐motor fluctuations, characterized by variability in mood and cognition, are prevalent in advanced Parkinson's disease (PD), but less is known about these fluctuations in early PD. Objective The objective was to characterize fluctuations in cognition and mood in early PD without cognitive impairment.
Abhimanyu Mahajan   +4 more
wiley   +1 more source

Research status of neurogenic supine hypertension

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2020
Neurogenic supine hypertensive (NSH) is one of the types of autonomic nervous function failure, often occurs in neurogenic orthostatic hypotension (NOH) patients.
Yan DING   +3 more
doaj  

Orthostatic Hypotension: Definition, Pathophysiology, Classification, Prognostic Aspects, Diagnostics and Treatment

open access: yesРациональная фармакотерапия в кардиологии, 2018
The urgency of the problem of orthostatic hypotension (OH) has increased in recent years. It was due to the high prevalence and its adverse effect on the prognosis and  quality of life of patients, especially the elderly and  oldest old.
O. D. Ostroumova   +3 more
doaj   +1 more source

The MSA Atrophy Index (MSA‐AI): An Imaging Marker for Diagnosis and Clinical Progression in Multiple System Atrophy

open access: yesAnnals of Clinical and Translational Neurology, Volume 12, Issue 9, Page 1823-1833, September 2025.
ABSTRACT Objective Reliable biomarkers are essential for tracking disease progression and advancing treatments for multiple system atrophy (MSA). In this study, we propose the MSA Atrophy Index (MSA‐AI), a novel composite volumetric measure to distinguish MSA from related disorders and monitor disease progression. Methods Seventeen participants with an
Paula Trujillo   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy